EPA’s Hospital Disinfectant List for Clostridium difficile Updated
For Release: February 10, 2014
The EPA has posted an updated list of registered antimicrobial products that are effective against the emerging pathogen Clostridium difficile. Clostridium difficile is among the most common emerging healthcare-associated infections. Healthcare-associated infections are infections that patients acquire during the course of receiving healthcare treatment for other conditions. C. difficile spores have been found on floors, sinks, toilets and other frequently-touched, contaminated surfaces in rooms of symptomatic and asymptomatic patients and may persist in the hospital environment for many months. Given the significant impact of hospital-acquired infections, it is critical that health care facilities be aware of registered products that are effective against pathogens such as Clostridium difficile. This updated information should be of particular interest to hospitals and others who buy antimicrobial products that make public health claims against Clostridium difficile.
For more information, please see the Selected EPA-registered Disinfectants web page.